Hawkeye Bio, Inc.
PrivateLast Round
Seed
Nov 30, 2019
Total Funding Raised
$250,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Hawkeye Bio, Inc. operates in Healthcare & Life Sciences and is based in Torrance, California. Its latest recorded funding round was a Seed round in November 2019.
Hawkeye Bio, Inc. is a biotechnology company that develops graphene-based biosensor technologies for the early detection and monitoring of cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Sensors, Precision Medicine, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hawkeye Bio, Inc. Comparables
Compare Hawkeye Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomark Diagnostics Inc. | 80% | |
| Delfi Diagnostics | 78% | |
| PrognomiQ | 77% |
For institutional investors. Book with your work email.
Hawkeye Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 30, 2019 | ||||
| Grant | Jun 1, 2019 |
For institutional investors. Book with your work email.
Hawkeye Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NJF Capital | Seed |
| Johnson & Johnson Innovation - JLABS | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 119% MoM.
- May 15, 2026
Monthly visitors increased 60% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 26, 2026
Hawkeye Bio and HealthQuest Esoterics announce commercial availability of LEAP, a prescription blood test that supports early lung cancer detection and complements low-dose CT screening, through HealthQuest's CLIA-certified laboratory in California on Oct 26th '26.
For institutional investors. Book with your work email.
Hawkeye Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hawkeye Bio, Inc.'s valuation, stock price, and market status.
Is Hawkeye Bio, Inc. a public or private company?
Hawkeye Bio, Inc. is a private company.
What is the current stock price of Hawkeye Bio, Inc.?
Hawkeye Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks Hawkeye Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hawkeye Bio, Inc. worth (valuation)?
Valuation information for Hawkeye Bio, Inc. is not publicly available.
Can I buy Hawkeye Bio, Inc. stock?
Hawkeye Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hawkeye Bio, Inc.'s last funding round?
Hawkeye Bio, Inc.'s most recent funding round was Seed on November 30, 2019.
Who are the main investors in Hawkeye Bio, Inc.?
Key investors in Hawkeye Bio, Inc. include NJF Capital, Johnson & Johnson Innovation - JLABS.
Will Hawkeye Bio, Inc. IPO soon?
No public IPO plans have been announced for Hawkeye Bio, Inc..
How can I track Hawkeye Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Hawkeye Bio, Inc.'s shares on secondary markets.